@article {yook2020pignol,
	title = {A dual receptor-targeted (DRT) radiation nanomedicine labeled with 177Lu is more potent for killing human breast cancer cells in vitro that co-express HER2 and EGFR than single receptor-targeted (SRT) radiation nanomedicines},
	journal = {Mol. Pharmaceutics},
	volume = {17},
	number = {4},
	year = {2020},
	pages = {1226{\textendash}1236},
	doi = {10.1021/acs.molpharmaceut.9b01259},
	author = {S. Yook and Z. Cai and J. J. Jeong and Y. Lu and M. A. Winnik and J-P. Pignol and R. M. Reilly}
}
